Objective: To analyze the effects of sildenafil citrate on clitoral blood flow and sexual response in postmenopausal women with orgasmic dysfunction. Method: In this randomized, double-blind, placebo-controlled trial 22 women received a 50-mg dose of sildenafil (n=11) or placebo (n=11) daily for 15 days. The Golombok Rust Inventory of Sexual Satisfaction (GRISS) was used for subjective evaluation of the sexual-response cycle. Clitoral blood flow was measured by color and pulse Doppler at baseline, after 1 hour of taking the first dose, and after 15 days of treatment. Results: Blood flow was significantly more improved in the sildenafit than in the placebo group (P<0.05), and a positive correlation between Doppler values and GRISS scores was...
INTRODUCTION: Oral contraceptives (OC) are effective for birth control and have good cycle control a...
Introduction. Aging and the decline of ovarian hormonal secretion during menopause may alter libido,...
INTRODUCTION: Sildenafil citrate is a type 5 phosphodiesterase inhibitor, which has demonstrated exc...
Objective: To analyze the effects of sildenafil citrate on clitoral blood flow and sexual response i...
Objective: The aim of this study was to determine the effect of sildenafil on the uterine circulatio...
OBJECTIVE: The aim of this study was to determine the effect of sildenafil on the uterine circulatio...
Objetivo: Avaliar os efeitos do citrato de sildenafila na circulação do clitóris em mulheres na pós-...
Female sexual dysfunction (FSD), in-cluding a common subclass referred to as female sexual arousal d...
ObjectiveTo evaluate sexual function in midlife women taking low-dose oral estradiol or venlafaxine ...
Background: Sexual dysfunction in women is prevalent and common in women after menopause. Many attem...
Female sexual arousal disorder (FSAD) is one of the subcategories of female sexual dysfunction (FSD)...
Objective: To evaluate the efficacy of two common interventions for bothersome postmenopausal vagin...
The clitoral blood flow increase is dependent of nitric oxide (NO) and it occurs due to sexual arous...
Objective: The present study investigated the cardiovascular, genital, and endocrine changes in wome...
Introduction: Female sexual arousal disorder is a pathophysiologic state characterized clinically by...
INTRODUCTION: Oral contraceptives (OC) are effective for birth control and have good cycle control a...
Introduction. Aging and the decline of ovarian hormonal secretion during menopause may alter libido,...
INTRODUCTION: Sildenafil citrate is a type 5 phosphodiesterase inhibitor, which has demonstrated exc...
Objective: To analyze the effects of sildenafil citrate on clitoral blood flow and sexual response i...
Objective: The aim of this study was to determine the effect of sildenafil on the uterine circulatio...
OBJECTIVE: The aim of this study was to determine the effect of sildenafil on the uterine circulatio...
Objetivo: Avaliar os efeitos do citrato de sildenafila na circulação do clitóris em mulheres na pós-...
Female sexual dysfunction (FSD), in-cluding a common subclass referred to as female sexual arousal d...
ObjectiveTo evaluate sexual function in midlife women taking low-dose oral estradiol or venlafaxine ...
Background: Sexual dysfunction in women is prevalent and common in women after menopause. Many attem...
Female sexual arousal disorder (FSAD) is one of the subcategories of female sexual dysfunction (FSD)...
Objective: To evaluate the efficacy of two common interventions for bothersome postmenopausal vagin...
The clitoral blood flow increase is dependent of nitric oxide (NO) and it occurs due to sexual arous...
Objective: The present study investigated the cardiovascular, genital, and endocrine changes in wome...
Introduction: Female sexual arousal disorder is a pathophysiologic state characterized clinically by...
INTRODUCTION: Oral contraceptives (OC) are effective for birth control and have good cycle control a...
Introduction. Aging and the decline of ovarian hormonal secretion during menopause may alter libido,...
INTRODUCTION: Sildenafil citrate is a type 5 phosphodiesterase inhibitor, which has demonstrated exc...